Hypertension Trial, Recruiting NCT05530512 Sponsor: University of California, Irvine Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05530512
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 45 and 75 years old
  • You have been diagnosed by a doctor with mild to moderate high blood pressure, whether or not you are currently taking medication for it, with blood pressure readings within a specific range (confirm with trial site for exact numbers)
  • Your resting heart tracing (ECG) does not show signs of reduced blood flow to the heart

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have been diagnosed with heart disease, certain abnormal heart rhythms, or blockages in the heart's electrical system
  • You have very low blood pressure (below 90 mmHg), disease affecting the blood vessels in your limbs, bone or joint problems that limit movement, nerve damage related to diabetes, or very severe high blood pressure
  • You have any other physical or mental health condition that may affect participation (confirm with trial site)
  • You have a known sensitivity or allergic reaction to skin creams, ointments, medical bandages, or sticky medical tapes
  • You are unwilling or unable to sign a written consent form agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Irvine
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in sympathetic and parasympathetic nervous systems

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov